Over 30 million acne patients seek treatment in the U.S. each year - - XYNGARI™ Phase 3 STAR-1 trial enrolled 520 patients with moderate-to-severe acne in the U.S. "We wish to thank the patients ...
Prosper’s retail footprint will continue to grow through the development’s future phases, said Fallon O’Neill, Blue Star Land ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback